Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free AVTE Stock Alerts $19.83 -1.73 (-8.02%) (As of 05:12 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Aerovate Therapeutics Stock Price Performance5 Day Performance-2.27%1 Month Performance-26.58%3 Month Performance-7.55%6 Month Performance+74.56%Year-To-Date Performance-12.37%1 Year Performance-6.20% Receive AVTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. AVTE Stock Chart for Friday, May, 10, 2024 AVTE Chart by TradingView Aerovate Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$21.04$21.56+2.47%$21.78$20.51128,462 shs$601.52 million05/08/2024$20.44$21.04+2.94%$21.20$19.82137,134 shs$587.02 million05/07/2024$20.62$20.44-0.87%$20.79$19.79142,515 shs$570.28 million05/06/2024$20.29$20.62+1.63%$20.86$20.22111,049 shs$592.56 million05/03/2024$20.75$20.29-2.22%$22.34$19.9999,949 shs$583.14 million05/02/2024$20.84$20.75-0.43%$21.21$20.21127,568 shs$596.36 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$20.01$20.84+4.15%$21.75$19.73152,803 shs$575.03 million04/30/2024$20.55$20.01-2.63%$20.69$19.6574,938 shs$557.48 million04/29/2024$21.75$20.55-5.52%$22.04$20.5156,084 shs$572.52 million04/26/2024$21.57$21.75+0.83%$22.39$21.1274,007 shs$605.96 million04/25/2024$21.20$21.57+1.75%$22.13$19.83119,830 shs$600.94 million04/24/2024$23.22$21.20-8.70%$23.93$21.10304,305 shs$590.63 million04/23/2024$22.17$23.22+4.74%$23.75$21.37148,258 shs$646.91 million04/22/2024$22.05$22.17+0.54%$22.87$21.35109,562 shs$617.66 million04/19/2024$21.60$22.05+2.08%$22.41$20.73218,786 shs$614.31 million04/18/2024$22.50$21.60-4.00%$22.44$20.96216,299 shs$601.78 million04/17/2024$23.62$22.50-4.74%$23.97$21.81159,191 shs$626.85 million04/16/2024$25.30$23.62-6.64%$25.58$23.47132,905 shs$658.05 million04/15/2024$25.24$25.30+0.24%$25.35$24.32106,784 shs$704.86 million04/12/2024$26.89$25.24-6.14%$27.11$24.44133,111 shs$703.19 million04/11/2024$27.01$26.89-0.44%$27.05$26.53142,551 shs$749.16 million04/10/2024$28.05$27.01-3.71%$27.79$26.22223,391 shs$752.50 million04/09/2024$26.48$28.05+5.93%$28.68$26.41132,128 shs$781.47 million04/08/2024$25.05$26.48+5.71%$26.58$24.51119,804 shs$737.73 million04/05/2024$29.10$25.05-13.92%$28.00$24.43246,223 shs$697.89 million04/04/2024$29.12$29.10-0.07%$30.29$28.77153,814 shs$810.73 million04/03/2024$29.58$29.12-1.56%$30.23$28.27179,635 shs$811.28 million04/02/2024$30.75$29.58-3.80%$29.97$28.45169,282 shs$824.10 million04/01/2024$29.57$30.75+3.99%$32.42$28.29295,749 shs$856.70 million03/29/2024$29.57$29.57$29.99$27.10216,915 shs$823.82 million03/28/2024$28.50$29.57+3.75%$29.99$27.10216,915 shs$823.82 million03/27/2024$25.65$28.50+11.11%$29.36$25.62922,344 shs$788.60 million03/26/2024$26.95$25.65-4.82%$27.32$24.27271,347 shs$709.74 million03/25/2024$25.78$26.95+4.54%$28.39$26.26224,601 shs$745.71 million03/22/2024$26.00$25.78-0.85%$26.78$25.4090,512 shs$713.33 million03/21/2024$25.89$26.00+0.42%$27.00$25.69188,505 shs$719.42 million03/20/2024$25.72$25.89+0.66%$27.34$25.36102,945 shs$716.38 million03/19/2024$26.39$25.72-2.54%$26.97$25.07100,094 shs$711.65 million03/18/2024$26.70$26.39-1.16%$27.12$25.24191,434 shs$730.21 million03/15/2024$24.29$26.70+9.92%$27.37$24.41105,613 shs$738.79 millionDo This Today BEFORE Biden Wins in November (Ad)Discover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video.03/14/2024$26.98$24.29-9.97%$26.87$23.9573,639 shs$672.08 million03/13/2024$24.14$26.98+11.76%$27.82$23.06104,171 shs$746.54 million03/12/2024$24.77$24.14-2.54%$25.20$23.28302,228 shs$667.95 million03/11/2024$26.52$24.77-6.60%$26.35$24.13124,970 shs$685.39 million03/08/2024$24.40$26.52+8.69%$27.20$23.52105,083 shs$733.81 million03/07/2024$23.87$24.40+2.22%$25.85$23.46143,651 shs$675.15 million03/06/2024$22.84$23.87+4.51%$24.10$22.3742,483 shs$660.48 million03/05/2024$22.49$22.84+1.56%$23.22$22.0644,281 shs$631.98 million03/04/2024$23.83$22.49-5.62%$23.96$22.4251,021 shs$622.30 million03/01/2024$23.08$23.83+3.25%$24.24$22.20108,483 shs$659.38 million02/29/2024$23.09$23.08-0.04%$24.17$22.3351,983 shs$638.60 million02/28/2024$23.77$23.09-2.86%$24.19$22.2251,375 shs$638.90 million02/27/2024$20.74$23.77+14.61%$24.49$19.99163,559 shs$657.72 million02/26/2024$19.63$20.74+5.65%$21.63$18.0870,687 shs$573.88 million02/23/2024$18.82$19.63+4.30%$20.10$18.8182,065 shs$543.16 million02/22/2024$18.85$18.82-0.16%$19.20$18.3995,812 shs$520.75 million02/21/2024$18.80$18.85+0.27%$19.44$18.11184,675 shs$521.58 million02/20/2024$20.91$18.80-10.09%$21.00$18.08219,186 shs$520.20 million02/19/2024$20.91$20.91$22.28$20.8180,200 shs$578.56 million02/16/2024$21.64$20.91-3.37%$22.28$20.8180,254 shs$578.58 million02/15/2024$19.25$21.64+12.42%$21.69$18.4765,784 shs$598.76 million02/14/2024$19.00$19.25+1.32%$19.86$18.0843,059 shs$532.65 million02/13/2024$20.40$19.00-6.86%$20.35$18.6990,466 shs$525.73 million02/12/2024$21.45$20.40-4.90%$22.20$20.0891,608 shs$564.47 million02/09/2024$20.53$21.45+4.48%$22.20$20.3487,966 shs$593.52 million Related Companies: ArriVent BioPharma Stock Chart IGM Biosciences Stock Chart Avid Bioservices Stock Chart Applied Therapeutics Stock Chart Astria Therapeutics Stock Chart Phathom Pharmaceuticals Stock Chart Arbutus Biopharma Stock Chart COMPASS Pathways Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Larimar Therapeutics Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.